Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 2018

View Archived Issues

Mutations mediate mantle cell lymphoma resistance

Rocket reports preclinical data on gene therapy RP-A501 for Danon disease

Fratricide-resistant, allo-tolerant "off-the-shelf" CAR-T cells for T-cell malignancies

Noncanonical activity of nuclear LDHA induced by ROS leads to HPV-induced cervical carcinogenesis

Novel LpxC inhibitors identified against Gram-negative bacteria by computational scaffold-hopping

Protagonist Therapeutics to begin clinical development of PN-10943 for IBD

Novus initiates phase I trial of OP-0201 for otitis media

Wayne State University, University of Zurich divulge apramycin derivatives

Wockhardt describes new antibacterials

Jivi approved in Europe for hemophilia A

Androgen receptor eliminators patented by Spg Therapeutics

Anti-inflammatory compositions presented by House Wellness Foods, House Foods Group

GlaxoSmithKline discovers sodium channel protein type 9 subunit alpha blockers

Blaze Bioscience initiates pivotal phase II/III study for of BLZ-100 and the Canvas Imaging System

Phase II trial opens in Congo to investigate multiple investigational Ebola therapies

FDA approves rituximab biosimilar Truxima to treat NHL

MedImmune presents new antibody-drug conjugates for cancer

New phase IIb trial investigates efficacy of male contraceptive gel

Xospata approved in U.S. for relapsed or refractory AML with FLT3 mutation

FDA approves Firdapse to treat Lambert-Eaton myasthenic syndrome

European Commission approves label extension for Kalydeco

EC grants approval to Delstrigo and Pifeltro for HIV-1 infection

European Commission approves Gilenya for children and adolescents with relapsing-remitting MS

Preclinical evaluation of next-generation retroviral vector with membrane-anchored IL-12

M-7824 demonstrates manageable safety and encouraging efficacy in rGBM

HMGA2 as potential new target for therapeutic strategies in medulloblastoma

Repurposing glioma exomes as novel strategy for multiantigenic antiglioma vaccination

Using cell free DNA from CSF provides less invasive technique to evaluate IDH1 mutation in glioma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...